Skip to ContentSkip to Navigation
About us Practical matters How to find us T.T. Wind

Publications

Biomarkers for response to immune checkpoint inhibitors in metastatic melanoma

Longitudinal gut microbiome changes in immune checkpoint blockade-treated advanced melanoma

A Survival Tree of Advanced Melanoma Patients with Brain Metastases Treated with Immune Checkpoint Inhibitors

Interleukin-2 PET imaging in patients with metastatic melanoma before and during immune checkpoint inhibitor therapy

Value of screening and follow-up brain MRI scans in patients with metastatic melanoma

Clinical utility of circulating tumor DNA as a response and follow-up marker in cancer therapy

Gut microbial species and metabolic pathways associated with response to treatment with immune checkpoint inhibitors in metastatic melanoma

A large pooled analysis refines gene expression-based molecular subclasses in cutaneous melanoma

Association Between Pembrolizumab-related Adverse Events and Treatment Outcome in Advanced Melanoma: Results From the Dutch Expanded Access Program

Zr-89-labeled Bispecific T-cell Engager AMG 211 PET Shows AMG 211 Accumulation in CD3-rich Tissues and Clear, Heterogeneous Tumor Uptake

Read more